SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Novartis
Novartis
Page 3 of 4
Health
The FDA Just Approved a Second Revolutionary Gene Therapy. A Third Is Probably on the Way
By
Sy Mukherjee
October 19, 2017
Health
Novartis CEO Joseph Jimenez Is Stepping Down
By
David Meyer
September 4, 2017
Health
Is $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
By
Sy Mukherjee
August 31, 2017
Commentary
Innovative Drugs Deserve Innovative Pricing
By
David Agus
,
Dana Goldman
and
Bethany Cianciolo
August 31, 2017
Health
The Way We Treat Cancer Will Be Revolutionized As Gene Therapy Comes to the U.S.
By
Sy Mukherjee
August 30, 2017
Health
This Drug Is A Dual Threat Against Heart Disease and Cancer
By
Clifton Leaf
August 28, 2017
Health
Investing in Healthcare: Two Starkly Different Views
By
Clifton Leaf
July 13, 2017
Health
FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers
By
Sy Mukherjee
July 12, 2017
Health
These World Leaders Have a Radical Idea for Health Care
By
Sy Mukherjee
April 27, 2017
Tech
Google and Novartis Won’t Be Testing Smart Contact Lenses This Year After All
By
Reuters
November 18, 2016
Health
Novartis Says MS Drug Cut Risk of Disability Advance in Study
By
Reuters
September 17, 2016
Health
Novartis Just Got Some Great News in Its Battle for Amgen’s Market Share
By
Sy Mukherjee
August 31, 2016
Health
Novartis Asthma Pill Shows Promise in Small Trial
By
Reuters
August 6, 2016
Health
Amgen Finally Scores a Win in Its Big Copycat Drug Battle With Novartis
By
Sy Mukherjee
July 19, 2016
Health
Two of the World’s Best-Selling Drugs Are Headed for a Lot More Competition
By
Sy Mukherjee
July 15, 2016
Most Popular
Success
Millionaire Alexis Ohanian walked out of the LSAT 20 minutes in, went to a Waffle House, and decided he was ‘gonna...
By
Preston Fore
Success
Multimillion-dollar restaurant CEO used to splurge on Range Rovers and McLarens—but he’s reining it in now because...
By
Emma Burleigh
Finance
CEO who ran tech unicorn once valued at $1.2 billion charged with fraud after allegedly spending millions on his...
By
Amanda Gerut